Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Compare and contrast: pediatric cancer versus adult malignancies.
Cancer Metastasis Rev. 2019 Dec;38(4):673-682. doi: 10.1007/s10555-019-09836-y.
Cancer Metastasis Rev. 2019.
PMID: 31832830
Review.
Temozolomide and Other Alkylating Agents in Glioblastoma Therapy.
Strobel H, Baisch T, Fitzel R, Schilberg K, Siegelin MD, Karpel-Massler G, Debatin KM, Westhoff MA.
Strobel H, et al. Among authors: fitzel r.
Biomedicines. 2019 Sep 9;7(3):69. doi: 10.3390/biomedicines7030069.
Biomedicines. 2019.
PMID: 31505812
Free PMC article.
Review.
Item in Clipboard
Considering the Experimental use of Temozolomide in Glioblastoma Research.
Herbener VJ, Burster T, Goreth A, Pruss M, von Bandemer H, Baisch T, Fitzel R, Siegelin MD, Karpel-Massler G, Debatin KM, Westhoff MA, Strobel H.
Herbener VJ, et al. Among authors: fitzel r.
Biomedicines. 2020 Jun 4;8(6):151. doi: 10.3390/biomedicines8060151.
Biomedicines. 2020.
PMID: 32512726
Free PMC article.
Review.
Item in Clipboard
Treatment response of advanced HNSCC towards immune checkpoint inhibition is associated with an activated effector memory T cell phenotype.
Schumacher M, Beer S, Moraes Ribeiro E, Korkmaz F, Keppeler H, Fitzel R, Erkner E, Radszuweit P, Lengerke C, Schneidawind C, Hoefert S, Mauz PS, Schneidawind D.
Schumacher M, et al. Among authors: fitzel r.
Front Oncol. 2024 Mar 7;14:1333640. doi: 10.3389/fonc.2024.1333640. eCollection 2024.
Front Oncol. 2024.
PMID: 38515578
Free PMC article.
Item in Clipboard
The RORɣ/SREBP2 pathway is a master regulator of cholesterol metabolism and serves as potential therapeutic target in t(4;11) leukemia.
Erkner E, Hentrich T, Schairer R, Fitzel R, Secker-Grob KA, Jeong J, Keppeler H, Korkmaz F, Schulze-Hentrich JM, Lengerke C, Schneidawind D, Schneidawind C.
Erkner E, et al. Among authors: fitzel r.
Oncogene. 2024 Jan;43(4):281-293. doi: 10.1038/s41388-023-02903-3. Epub 2023 Nov 29.
Oncogene. 2024.
PMID: 38030791
Free PMC article.
Item in Clipboard
Uncovering NOTCH1 as a Promising Target in the Treatment of MLL-Rearranged Leukemia.
Fischer J, Erkner E, Fitzel R, Radszuweit P, Keppeler H, Korkmaz F, Roti G, Lengerke C, Schneidawind D, Schneidawind C.
Fischer J, et al. Among authors: fitzel r.
Int J Mol Sci. 2023 Sep 23;24(19):14466. doi: 10.3390/ijms241914466.
Int J Mol Sci. 2023.
PMID: 37833915
Free PMC article.
Item in Clipboard
Targeting MYC in combination with epigenetic regulators induces synergistic anti-leukemic effects in MLLr leukemia and simultaneously improves immunity.
Fitzel R, Secker-Grob KA, Keppeler H, Korkmaz F, Schairer R, Erkner E, Schneidawind D, Lengerke C, Hentrich T, Schulze-Hentrich JM, Schneidawind C.
Fitzel R, et al.
Neoplasia. 2023 Jul;41:100902. doi: 10.1016/j.neo.2023.100902. Epub 2023 May 4.
Neoplasia. 2023.
PMID: 37148657
Free PMC article.
Item in Clipboard
Cite
Cite